Newest A-Z
VAC-MAC: VACcination of patients with MS/Arthritis/Colitis
>Federal Joint Committee | Innovation Fund
Statistical AnalysesClaims data
OnCoPaTh – OncoCoaching and early palliative care in the therapy of incurable cancer
>Federal Joint Committee | Innovation Fund
Statistical AnalysesEvaluation
VersKiK – Care following childhood or adolescent cancer
>Federal Joint Committee | Innovation Fund
Statistical AnalysesData infrastructure
GestDiNa_basic – Aftercare for gestational diabetes
>Federal Joint Committee | Innovation Fund
Statistical AnalysesSupply curves
BARMER Pharmaceutical Report
>BARMER
Statistical AnalysesPharmacotherapy
CoRe-Net – Cologne Research and Development Network
>Federal Ministry of Education and Research BMBF
Statistical AnalysesPopulation health
Risk evaluation and effectiveness of COVID19 vaccines RiCO
>Federal Ministry of Health
Statistical AnalysesData linkage
REVASK – Care analysis for myocardial revascularization therapy
>Federal Joint Committee | Innovation Fund
Statistical AnalysesSupply curves
EVITA – Evidence-based multi-medication program
>Federal Joint Committee | Innovation Fund
Statistical AnalysesDevelopment of Guidelines
DiViDe - Frequency of Diagnosis and Care of Hearing Impairment in Children and Adolescents in Germany
>KIND Hearing Foundation, International Hearing Foundation
Statistical AnalysesDisease incidence
K-APAT – Outpatient parenteral antibiotic therapy in the Cologne metropolitan region
>Federal Joint Committee | Innovation Fund
Statistical AnalysesData preparation
Estimation of the prevalence and incidence of hyperkinetic disorder and its treatment
>Own resources
Statistical AnalysesDisease incidence
Dent@Prevent – Implementation of claims data & PROMS into (dental) medical care
>Federal Joint Committee | Innovation Fund
Statistical AnalysesDisease incidence
Evaluation of data from quality assurance stroke Baden-Württemberg
>University Hospital Heidelberg
Statistical AnalysesRegister data
Gestational diabetes
>Zentralinstitut für die Kassenärztliche Versorgung in Deutschland Zi
Statistical AnalysesPrevention
Analysis of the prescription of Valproat and related substances over time
>Federal Institute for Drugs and Medical Devices BfArM
Statistical AnalysesPharmacotherapy
ADVOCATE – Added Value for Oral Care
>Horizon 2020 | EU-Project
Statistical AnalysesData linkage
INTEGRAL – 10-Year evaluation of the integrated care Gesundes Kinzigtal
>Federal Joint Committee | Innovation Fund
Statistical AnalysesEvaluation
APVEL – Evaluation of specialised outpatient palliative care
>Federal Joint Committee | Innovation Fund
Statistical AnalysesEvaluation
Determination of the SHI target population for the indication diabetes mellitus type 2 using SHI routine data
>IQWiG
Statistical AnalysesClaims data
Chronic rheumatic diseases in women of childbearing age
>UCB Pharma GmbH
Statistical AnalysesClaims data
Operationalisation and frequency estimation of a statin intolerance
>Sanofi-Aventis Deutschland GmbH
Statistical AnalysesPharmacotherapy
Evaluation of the integrated care approache »Gesundes Kinzigtal«
>Gesundes Kinzigtal GmbH
Statistical AnalysesEvaluation
CONTRIBUTE - Switch from OFF-Label & Best Supportive Care to approved therapies in various autoimmune diseases: Implementation, impact on disease progression and adverse events
>Federal Joint Committee | Innovation Fund
Statistical AnalysesSupply curves
prevCOV – Improving the prevention and treatment of Long COVID and Post-VAC
>Federal Ministry of Health (BMG)
Statistical AnalysesDisease incidence
COVYOUTHdata - Early detection, understanding and management of long-term consequences of COVID-19 in children and adolescents
>Federal Ministry of Health (BMG)
Statistical AnalysesDisease incidence
METHODS
TOPICS
DATA
